159 related articles for article (PubMed ID: 22159564)
1. Haemostatic variables during normal menstrual cycle. A systematic review.
Knol HM; Kemperman RF; Kluin-Nelemans HC; Mulder AB; Meijer K
Thromb Haemost; 2012 Jan; 107(1):22-9. PubMed ID: 22159564
[TBL] [Abstract][Full Text] [Related]
2. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
Chaireti R; Gustafsson KM; Byström B; Bremme K; Lindahl TL
Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
[TBL] [Abstract][Full Text] [Related]
3. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive.
Kadir RA; Economides DL; Sabin CA; Owens D; Lee CA
Thromb Haemost; 1999 Nov; 82(5):1456-61. PubMed ID: 10595638
[TBL] [Abstract][Full Text] [Related]
4. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation.
Andersson O; Blombäck M; Bremme K; Wramsby H
Thromb Haemost; 1997 May; 77(5):901-4. PubMed ID: 9184400
[TBL] [Abstract][Full Text] [Related]
5. Alterations in platelet function during the ovarian cycle.
Feuring M; Christ M; Roell A; Schueller P; Losel R; Dempfle CE; Schultz A; Wehling M
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):443-7. PubMed ID: 12138372
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic and fibrinolytic properties of peritoneal fluid in the menstrual cycle.
Bouckaert PX; van Wersch JW; Schellekens LA; Evers JL; Rolland R
Br J Obstet Gynaecol; 1984 Mar; 91(3):256-9. PubMed ID: 6422977
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle.
Koh SC; Prasad RN; Fong YF
Clin Appl Thromb Hemost; 2005 Jul; 11(3):295-301. PubMed ID: 16015415
[TBL] [Abstract][Full Text] [Related]
8. Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women.
Larsen LF; Andersen HR; Hansen AB; Andersen O
Scand J Clin Lab Invest; 1996 May; 56(3):241-9. PubMed ID: 8761528
[TBL] [Abstract][Full Text] [Related]
9. Dynamic variability of hemostatic and fibrinolytic factors in young women.
Giardina EG; Chen HJ; Sciacca RR; Rabbani LE
J Clin Endocrinol Metab; 2004 Dec; 89(12):6179-84. PubMed ID: 15579775
[TBL] [Abstract][Full Text] [Related]
10. Haemostatic risk factors for cardiovascular diseases.
Koenig W
Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolysis during the normal menstrual cycle.
Siegbahn A; Odlind V; Hedner U; Venge P
Ups J Med Sci; 1989; 94(2):137-52. PubMed ID: 2527430
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic variables in patients with unstable angina.
al-Nozha M; Gader AM; al-Momen AK; Noah MS; Jawaid M; Arafa M
Int J Cardiol; 1994 Mar; 43(3):269-77. PubMed ID: 8181885
[TBL] [Abstract][Full Text] [Related]
13. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
[TBL] [Abstract][Full Text] [Related]
14. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
[TBL] [Abstract][Full Text] [Related]
15. Monthly haemostatic factor variability in women and men.
Hill AM; Stewart PW; Fung MK; Kris-Etherton PM; Ginsberg HN; Tracy RP; Pearson TA; Lefevre M; Reed RG; Elmer PJ; Holleran S; Ershow AG;
Eur J Clin Invest; 2014; 44(3):309-18. PubMed ID: 24382103
[TBL] [Abstract][Full Text] [Related]
16. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
17. Obesity, haemostasis and the fibrinolytic system.
Mertens I; Van Gaal LF
Obes Rev; 2002 May; 3(2):85-101. PubMed ID: 12120424
[TBL] [Abstract][Full Text] [Related]
18. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers.
Pellegrini N; Pareti FI; Stabile F; Brusamolino A; Simonetti P
Eur J Clin Nutr; 1996 Apr; 50(4):209-13. PubMed ID: 8730606
[TBL] [Abstract][Full Text] [Related]
19. Neonatal haemostatic parameters in correlation to gestational age and birth weight.
Mitsiakos G; Katsaras GN; Pouliakis A; Papadakis E; Chatziioannidis I; Mitsiakou C; Gialamprinou D; Papacharalampous E; Kioumi A; Athanasiou M; Athanassiadou F; Sfoungaris D; Nikolaidis N
Int J Lab Hematol; 2022 Oct; 44(5):952-958. PubMed ID: 35815444
[TBL] [Abstract][Full Text] [Related]
20. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
